what are the Recommendations for Cardio-Oncology
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In patients who develop cancer therapy?related cardiomyopathy or HF, a multidisciplinary discussion involving the patient about the risk- benefit ratio of cancer therapy interruption, dis- continuation, or continuation is recommended to improve management.